The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 16, 2023

Filed:

Aug. 10, 2020
Applicant:

Société Des Produits Nestlé S.a., Vevey, CH;

Inventors:

Timothy James Wooster, Epalinges, CH;

Ebenezer Satyaraj, Wildwood, MO (US);

Eddy Gombas, Lausanne, CH;

Beat Gerber, Moudon, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 47/42 (2017.01); A61K 9/00 (2006.01); A61K 39/395 (2006.01); A61K 47/36 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 9/006 (2013.01); A61K 39/395 (2013.01); A61K 47/36 (2013.01); A61K 47/42 (2013.01); A23V 2002/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/92 (2013.01);
Abstract

Compositions and methods reduce symptoms of human allergy to cats. The effectiveness of a molecule which specifically binds to Feline domesticus allergen number 1 (Fel D1) is enhanced by prolonging the time the immunoglobulin stays within the mouth of a cat to whom the anti-Fel D1 molecule is administered in a pet food. The compositions and methods use a powder that is a dried hydrogel encapsulating the anti-Fel D1 molecule, and the hydrogel is based on gelatin, collagen peptides, or gelatin and collagen peptides; and carrageenan. The methods of making the powder provide a high encapsulation efficacy, sustained release of the anti-Fel D1 molecule in the cat's mouth, and oral adhesion of the anti-Fel D1 molecule in the cat's mouth.


Find Patent Forward Citations

Loading…